Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9616 posts found.

pfizer_logo

Pfizer’s Xeljanz denied plaque psoriasis indication by FDA

October 16, 2015 Research and Development, Sales and Marketing FDA, Pfizer, Xeljanj, tofacitinib

The FDA has rejected the indication expansion of Pfizer’s Xeljanz (tofacitinib) for treatment of moderate to severe cases of plaque psoriasis. …
News
T-cell

$350m collaboration deal for BMS and Five Prime Therapeutics

October 15, 2015 Research and Development BMS, Bristol-Myers Squibb, R&D, five prime, immuno-oncology, tumours

Bristol-Myers Squibb has signed a collaboration agreement with the US biotech firm Five Prime Therapeutics, for a Colony Stimulating Factor …
News
Ablynx flags

Ablynx and Merck begin immuno-oncology collaboration

October 15, 2015 Research and Development Ablynx, Merck, immuno-oncology, nanobody, proof of concept

Ablynx has achieved a pre-clinical proof-of-concept with a nanobody construct as part of its immuno-oncology collaboration with Merck – triggering …
News

Crescendo Biologics appoints Dr Peter Pack as chief exec

October 15, 2015 Business Services, Research and Development

Crescendo Biologics has announced the appointment of Dr Peter Pack as chief executive, who will oversee the company’s new drug …
Appointment
MSD logo

Merck and Incyte to initiate Keytruda, epacadostat combo trial

October 15, 2015 Research and Development Incyte, Merck, R&D, melanoma, phase III, skin cancer

Merck and biopharma firm Incyte are to expand their clinical collaboration to include a Phase III study evaluating the combination …
News
ebola_virus

Johnson & Johnson begins Ebola vaccine trial in Sierra Leone

October 14, 2015 Research and Development Ebola vaccine, Johnson & Johnson

Johnson & Johnson has begun a safety and immunogenicity clinical trial in Sierra Leone of a preventive Ebola vaccine regimen …
News
boris_johnson_in_japan

Mayor of London announces Takeda, UCL R&D partnership

October 14, 2015 Research and Development London, R&D, Takeda, UCL, neurology

Takeda is teaming up with researchers at University College London (UCL) to identify and validate novel target genes for the …
News
erik_j

Lisa Rae Schopf and Erik J. Spek bolster Vedanta Biosciences team

October 14, 2015 Medical Communications, Research and Development

Vedanta Biosciences, a PureTech Health company developing a new class of therapies designed to modulate the human microbiome, has announced …
Appointment

Merck rebrands as ‘science and technology’ company

October 14, 2015 Medical Communications, Research and Development, Sales and Marketing Merck, Merck Millipore, Merck Serono, rebrand, restructure

Merck Group has rebranded to “reflect its transformation into a science and technology company”, and restructured its business to create …
News
Teva image

Teva joins Watson Health in R&D link-up

October 14, 2015 Research and Development Big Data, R&D, Teva, Watson Health, ibm

Teva has partnered with the IBM Watson Health Cloud to create a global technology platform to aid its R&D efforts …
News
dna

Featured Market Report: Gene Therapies Outlook

October 13, 2015 Manufacturing and Production, Research and Development

This report provides a comprehensive view of the clinical, R&D, commercial and competitive landscape of gene therapy, and assesses key …
Feature
cinryze_logo

Shire’s Cinryze gets FDA fast track designation

October 13, 2015 Research and Development AMR, FDA, Shire

Shire has announced that the United States Food and Drug Administration (FDA) has granted fast track designation for the investigation …
News
medimmune_2

AstraZeneca’s MedImmune joins Human Vaccines Project

October 13, 2015 Research and Development Human Vaccines Project, MedImmune

MedImmune has joined the Human Vaccines Project, which aims to accelerate the research and development of vaccines and immunotherapies for …
News
gamidi_cell_logo

Novartis invests further $15m into Gamida Cell

October 13, 2015 Research and Development, Sales and Marketing Gamida Cell, Novartis, pharma mergers and acquisitions

Novartis is to invest an extra $15 million into Israeli stem cell therapy developer Gamida Cell, adding an additional 2.5% …
News
s_oschmann_2015

Stefan Oschmann promoted to top job at Merck KGaA

October 13, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Merck KGaA, Stefan Oschmann

Merck KGaA has announced the promotion of its deputy chief executive, Stefan Oschmann, to the role of chief executive, starting …
Appointment
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026